RPHM: Reneo Pharmaceuticals, Inc. Stock

by  •  • Comments Off on RPHM: Reneo Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 55.98
Enterprise Value ($M) 28.35
Book Value ($M) 88.61
Book Value / Share 2.65
Price / Book 0.63
NCAV ($M) 87.80
NCAV / Share 2.63
Price / NCAV 0.64

Profitability (mra)
Return on Invested Capital (ROIC) -0.86
Return on Assets (ROA) -0.78
Return on Equity (ROE) -0.89

Liquidity (mrq)
Quick Ratio 5.87
Current Ratio 5.87

Balance Sheet (mrq) ($M)
Current Assets 106.62
Assets 107.44
Liabilities 18.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -82.40
Net Income -77.39

Cash Flow Statement (mra) ($M)
Cash From Operations -63.68
Cash from Investing 10.52
Cash from Financing 60.87

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-05 13G Octagon Capital Advisors LP 6.75
01-17 13G BML Investment Partners, L.P. 5.10 0.00
12-26 13D Tang Capital Partners Lp 10.00
12-15 13D/A Novo Holdings A/S 0.00 -100.00
05-30 13D/A RiverVest Venture Fund III, L.P. 7.53 5.19
05-09 13D/A Carlyle Group Inc. 8.20 30.77

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 33,077 131,491 25.16
2024-04-23 14,298 70,337 20.33
2024-04-22 57,646 43,930 131.22
2024-04-19 10,235 15,295 66.92

(click for more detail)

Similar Companies
RLAY – Relay Therapeutics, Inc. RNA – Avidity Biosciences, Inc.
RNAC – Cartesian Therapeutics, Inc. RVNC – Revance Therapeutics, Inc.
RWOD – Redwoods Acquisition Corp.


Financial data and stock pages provided by
Fintel.io